EverHint – SMA 20/50 Crossover, EMA 10 + Price + MACD, EMA 10/30 Crossover – Top 28 Buy and Top 10 Sell Signals for May 28, 2026
Market Context
Equity markets are displaying a constructive risk-on tone, with the Nasdaq leading gains at +0.90% and the S&P 500 adding +0.57%, while the Dow Jones lagged with a modest +0.05% advance. This divergence between large-cap growth and blue-chip value names suggests investors are favoring higher-beta, momentum-driven opportunities — an environment that tends to amplify the effectiveness of trend-following strategies like the EMA 10/30 and SMA 20/50 crossovers. When growth indices outpace value, crossover signals generated in momentum-sensitive sectors carry higher follow-through probability.
Volatility conditions are notably supportive for signal quality. The VIX sitting at 15.64, down nearly 4% on the session, reflects a low-fear environment with compressed implied volatility. For intraday traders, this means tighter price swings and reduced noise, which benefits MACD-based and EMA confirmation strategies by producing cleaner, less whipsaw-prone signals. However, traders should remain aware that very low VIX readings can precede sudden volatility spikes, so position sizing discipline remains important.
Healthcare emerging as the top sector aligns with a broader pattern of defensive rotation occurring alongside the growth rally — a sign that risk appetite is present but not unchecked. This dual leadership dynamic, growth and defensive sectors both attracting capital simultaneously, suggests the market is in a measured expansion phase rather than speculative excess. Signal strategies deployed in Healthcare may benefit from steadier, more sustained trending behavior compared to more cyclical sectors, making trend-confirmation entries particularly relevant in the current environment.
SMA 20/50 Crossover
Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.
Entry Criteria:
- Buy: SMA20 crosses above SMA50
- Sell: SMA20 crosses below SMA50
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 2-6 weeks | Risk level: Medium
🟢 Buy Signals (3 of 3)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | Earnings | MCap |
|---|---|---|---|---|---|---|
| 1 | AA | Alcoa Corporation | Basic Materials | $75.62 | — | $20.0B |
| 2 | IQV | IQVIA Holdings Inc. | Healthcare | $181.09 | — | $30.2B |
| 3 | UNF | UniFirst Corporation | Industrials | $268.03 | — | $4.9B |
🔴 Sell Signals (5 of 6)
| # | Ticker | Company | Sector | Price | Earnings | MCap |
|---|---|---|---|---|---|---|
| 1 | ACHC | Acadia Healthcare Comp... | Healthcare | $23.76 | — | $2.2B |
| 2 | BOKF | BOK Financial Corporation | Financial Services | $129.04 | — | $7.8B |
| 3 | CLH | Clean Harbors, Inc. | Industrials | $280.71 | — | $14.8B |
| 4 | ITT | ITT Inc. | Industrials | $193.35 | — | $17.3B |
| 5 | ODFL | Old Dominion Freight L... | Industrials | $220.86 | — | $45.9B |
EMA 10 + Price + MACD
Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.
Entry Criteria:
- Buy: Price > EMA10 AND MACD line crosses above signal line
- Sell: Price < EMA10 AND MACD line crosses below signal line
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh signal: All conditions met on today's close
Holding period: 1-3 weeks | Risk level: Medium-High
🟢 Buy Signals (10 of 10)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | Earnings | MCap |
|---|---|---|---|---|---|---|
| 1 | ALKT | Alkami Technology, Inc. | Technology | $17.59 | — | $1.9B |
| 2 | CAI | Caris Life Sciences, Inc. | Healthcare | $16.67 | — | $4.7B |
| 3 | CDE | Coeur Mining, Inc. | Basic Materials | $18.59 | — | $12.1B |
| 4 | CHWY | Chewy, Inc. | Consumer Cyclical | $21.38 | — | $8.9B |
| 5 | DNTH | Dianthus Therapeutics,... | Healthcare | $90.86 | — | $3.8B |
| 6 | EXLS | ExlService Holdings, Inc. | Technology | $29.11 | — | $4.4B |
| 7 | IQV | IQVIA Holdings Inc. | Healthcare | $181.09 | — | $30.2B |
| 8 | TDY | Teledyne Technologies ... | Technology | $634.06 | — | $29.4B |
| 9 | VERA | Vera Therapeutics, Inc. | Healthcare | $35.86 | — | $2.6B |
| 10 | XRAY | DENTSPLY SIRONA Inc. | Healthcare | $10.29 | — | $2.1B |
EMA 10/30 Crossover
Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.
Entry Criteria:
- Buy: EMA10 crosses above EMA30
- Sell: EMA10 crosses below EMA30
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 1-4 weeks | Risk level: Medium
🟢 Buy Signals (15 of 39)
Ranked by RSI (lower RSI for buy signals = more oversold)
| # | Ticker | Company | Sector | Price | Earnings | MCap |
|---|---|---|---|---|---|---|
| 1 | A | Agilent Technologies, ... | Healthcare | $135.42 | -2d | $38.3B |
| 2 | ALLY | Ally Financial Inc. | Financial Services | $42.80 | — | $13.1B |
| 3 | AMR | Alpha Metallurgical Re... | Basic Materials | $213.72 | — | $2.7B |
| 4 | ANET | Arista Networks, Inc. | Technology | $155.27 | — | $195.5B |
| 5 | ASAN | Asana, Inc. | Technology | $6.66 | 4d | $1.6B |
| 6 | AVTR | Avantor, Inc. | Healthcare | $9.15 | — | $6.2B |
| 7 | BETA | BETA Technologies, Inc. | Industrials | $18.33 | — | $4.1B |
| 8 | CCL | Carnival Corporation &... | Consumer Cyclical | $27.94 | — | $38.7B |
| 9 | CRSP | CRISPR Therapeutics AG | Healthcare | $56.38 | — | $5.4B |
| 10 | DDS | Dillard's, Inc. | Consumer Cyclical | $608.68 | — | $9.5B |
| 11 | DNLI | Denali Therapeutics Inc. | Healthcare | $20.95 | — | $3.3B |
| 12 | ERO | Ero Copper Corp. | Basic Materials | $29.86 | — | $3.1B |
| 13 | FLG | Flagstar Financial, Inc. | Financial Services | $14.17 | — | $5.9B |
| 14 | FTAI | FTAI Aviation Ltd. | Industrials | $262.78 | — | $27.0B |
| 15 | FUL | H.B. Fuller Company | Basic Materials | $63.59 | — | $3.5B |
🔴 Sell Signals (5 of 28)
| # | Ticker | Company | Sector | Price | Earnings | MCap |
|---|---|---|---|---|---|---|
| 1 | AIG | American International... | Financial Services | $74.40 | — | $39.4B |
| 2 | ALL | The Allstate Corporation | Financial Services | $207.28 | — | $53.4B |
| 3 | AM | Antero Midstream Corpo... | Energy | $21.16 | — | $10.1B |
| 4 | AMX | América Móvil, S.A.B. ... | Communication Services | $25.79 | — | $77.5B |
| 5 | AROC | Archrock, Inc. | Energy | $34.60 | — | $6.1B |
Field Notes
Sector concentration: Healthcare (17), Industrials (14), Technology (12)
Near-term earnings: A (Agilent Technologies, Inc.), ASAN (Asana, Inc.) report within 7 days. Higher volatility risk.
Data coverage: 0.0% insider, 0.0% congressional, 4.7% earnings, 5.8% news
Vlad's Take
Today's signals: Strong sector concentration in Healthcare (17 signals) suggests sector-specific rotation.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 If you found this useful, a quick like, share, or subscribe keeps EverHint moving forward.